American Cyanamid Signs Gene Product Agreement with Hyseq

P

ARSIPPANY, NJ--American Cyanamid and Hyseq announced last month that they have entered a multiyear agreement to discover agriculturally relevant genes using Hyseq’s high-throughput genomics and bioinformatics technologies. The deal also calls for the companies to use Hyseq’s proprietary technology to develop products for use in crop protection, crop production, nutraceuticals, human and animal foodstuffs, industrial products, and chemical intermediates, as well as plant-based pharmaceuticals. Under the terms of the agreement, Hyseq will receive $60 million in revenues over a 3.5 year period and future royalty payments for products originating from the collaboration.